Qualigen Therapeutics Presents Data on QN-302 at AACR's : vi

Posters include data regarding 1) mode of action, and 2) preclinical toxicology CARLSBAD, Calif., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Qualigen...

Related Keywords

Boston , Massachusetts , United States , American , Stephen Neidle , Jules Abraham , Tariq Arshad , Ahmed , Exchange Commission , Partners Inc , American Academy Of Cancer Research , Qualigen Therapeutics Inc , Aboutqualigentherapeutics Inc , Nasdaq , Orphan Drug Designation , American Academy , Cancer Research , Special Conference , Pancreatic Cancer , Chief Medical , Investigational New Drug , Qualigen Therapeutics , Fast Track , Orphan Drug , Private Securities Litigation Reform Act , Nasdaq Qlgn , Nc , Algn , Racr , N 302 ,